Streetbeat News

Regulatory

SLN

Silence Therapeutics plc (Nasdaq: SLN) announced positive 36-week data from the ALPACAR-360 phase 2 study of zerlasiran in subjects with high Lp(a) levels, a key risk factor for cardiovascular disease. Zerlasiran aims to lower Lp(a) production, potentially reducing the risk of atherosclerotic cardiovascular disease events.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 11:01 am

PEPG

PepGen announced that it has received U.S. FDA Orphan Drug and Rare Pediatric Disease designations for PGN-EDO51, aimed at treating Duchenne Muscular Dystrophy. These designations can provide certain benefits, including tax credits and eligibility for seven years of market exclusivity upon approval.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 11:01 am

FXI

China's financial regulator plans to foster a positive relationship between the finance and real estate sectors, ensuring the reasonable financial needs of real estate enterprises are met and speeding up the implementation of an urban real estate financing coordination mechanism.

Portfolio Pulse from Charles Gross

March 13, 2024 | 10:40 am

RIOT

Pierre Rochard, VP of Research at Riot Platforms, claims the White House's 2025 budget implies a Bitcoin price target of $250,000 by 2035, sparking debate. Critics argue the budget focuses on digital asset taxation, not price predictions. Rochard defends his analysis, suggesting the budget's optimistic revenue projections from digital assets hint at significant Bitcoin growth. The budget indeed proposes measures to regulate and tax cryptocurrency activities, aiming to generate substantial revenue.

Portfolio Pulse from Murtuza Merchant

March 13, 2024 | 10:02 am

CYBN

Cybin announced that it has received FDA Breakthrough Therapy Designation for its novel psychedelic molecule, CYB003, aimed at treating Major Depressive Disorder (MDD). Additionally, the company shared positive four-month durability data for CYB003 in MDD, indicating sustained efficacy over time.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 10:01 am

TSLA

Elon Musk, CEO of Tesla (TSLA) and SpaceX, responded with 'Of course' to a post about Russian President Vladimir Putin's warning of nuclear war readiness against the U.S. if troops are sent to Ukraine. Putin's statement highlights the escalating tensions between Russia and the West, amid the ongoing war in Ukraine. The U.S. has been preparing for a potential Russian nuclear strike, while Russia plans to establish a nuclear power plant on the moon by 2035 in collaboration with China.

Portfolio Pulse from Benzinga Neuro

March 13, 2024 | 8:56 am

TSLA

Tesla Inc (NASDAQ:TSLA) supports a shareholder's petition to the NHTSA for not classifying over-the-air (OTA) software updates as 'recalls' and to allow electronic recall notifications. The petition, initiated by Tesla investor Sawyer Merritt, argues for environmental and cost benefits, and for a better understanding of vehicle safety through modern notification methods. Elon Musk has criticized the current recall terminology, especially after a recent 'recall' involving 2.2 million vehicles for a minor software fix.

Portfolio Pulse from Anan Ashraf

March 13, 2024 | 8:13 am

PFE

The European Commission has granted Pfizer's PREVENAR 20 vaccine marketing authorization in the EU for protecting infants and children up to 18 years against pneumococcal disease.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 8:02 am

TIP

Economist Peter Schiff warns of rising inflation, criticizing the Federal Reserve and Chair Jerome Powell for ineffective measures. Schiff predicts inflation could reach double digits, diverging from the Fed's 2% target. The February inflation report showed an increase, and Schiff highlighted the federal budget deficit's growth. Despite these concerns, the iShares TIPS Bond ETF (TIP) experienced a slight decline.

Portfolio Pulse from Shanthi Rexaline

March 13, 2024 | 7:52 am

AAPL

Jim Cramer, host of CNBC's 'Mad Money,' has advised investors to maintain their holdings in Apple Inc (NASDAQ:AAPL) despite recent challenges, including a stock price drop, regulatory issues, and slow iPhone sales in China. Cramer emphasized patience and highlighted potential long-term gains from AI-integrated iPhones and the resolution of China-related concerns. Contrarily, Bank of America and Evercore ISI are optimistic about Apple's future, citing increased market share and potential growth drivers like AI integration and the Services business.

Portfolio Pulse from Benzinga Neuro

March 13, 2024 | 5:46 am